Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

716
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
716
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

389
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
389
Neural Regulation01:37

Neural Regulation

40.3K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

L-Dopa/Carbidopa intestinal gel infusion in advanced Parkinson's disease: real-life mobility insights from wearable sensors.

Frontiers in neurology·2026
Same author

Editorial: Technological Advances for Gait and Balance Assessment.

Bioengineering (Basel, Switzerland)·2026
Same author

Preserved gaze cueing in Parkinson's disease: Differential temporal modulation of social and non-social attentional orienting.

Behavioural brain research·2026
Same author

Association Between Freezing of Gait and Sleep Quality in People with Parkinson's Disease.

Brain sciences·2026
Same author

Reorganization of functional brain network architecture in SPG4: Evidence from resting-state fMRI.

Parkinsonism & related disorders·2026
Same author

Rigidity in Parkinson's disease.

Brain : a journal of neurology·2026
Same journal

Correction to "Advancing Neuromodulation for Functional Movement Disorders: A Contemporary Narrative Review of Evidence, Gaps, and Future Outlook".

Movement disorders clinical practice·2026
Same journal

Efficacy of IncobotulinumtoxinA (BoNT-A) Injections in Upper Limb Task-Specific and Position-Dependent Tremors.

Movement disorders clinical practice·2026
Same journal

Health-Related Quality of Life in Children with Primary Complex Motor Stereotypies.

Movement disorders clinical practice·2026
Same journal

7 T MRI Connectivity-Guided Reprogramming Improves Deep Brain Stimulation Motor Outcome in Parkinson's Disease.

Movement disorders clinical practice·2026
Same journal

Cutis Verticis Gyrata in SPG11-Related Hereditary Spastic Paraplegia: A Potential Novel Association.

Movement disorders clinical practice·2026
Same journal

"Familial Is Not Always Genetic: Two Brothers with Dystonia and Oculomotor Apraxia Secondary to Rh Incompatibility-Induced Kernicterus".

Movement disorders clinical practice·2026
See all related articles

Related Experiment Video

Updated: Sep 16, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K

Micrographia in Parkinson's Disease: Automatic Recognition through Artificial Intelligence.

Francesco Asci1, Gaetano Saurio2, Giulia Pinola3

  • 1Department of Neurosciences and Sensory Organs, AO San Giovanni-Addolorata, Rome, Italy.

Movement Disorders Clinical Practice
|July 7, 2025
PubMed
Summary
This summary is machine-generated.

Parkinson's disease (PD) handwriting changes, known as micrographia, appear early and worsen over time. Artificial intelligence (AI) analysis shows this condition poorly responds to L-Dopa treatment.

Keywords:
Parkinson's diseaseartificial intelligencehandwritingmachine learningtelemedicine

More Related Videos

Digital Handwriting Analysis of Characters in Chinese Patients with Mild Cognitive Impairment
05:58

Digital Handwriting Analysis of Characters in Chinese Patients with Mild Cognitive Impairment

Published on: March 11, 2021

4.7K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.0K

Related Experiment Videos

Last Updated: Sep 16, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.4K
Digital Handwriting Analysis of Characters in Chinese Patients with Mild Cognitive Impairment
05:58

Digital Handwriting Analysis of Characters in Chinese Patients with Mild Cognitive Impairment

Published on: March 11, 2021

4.7K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.0K

Area of Science:

  • Neurology
  • Artificial Intelligence
  • Biomedical Engineering

Background:

  • Parkinson's disease (PD) is characterized by micrographia, a reduction in handwriting size.
  • The early onset, progression, and L-Dopa responsiveness of micrographia in PD remain debated.

Purpose of the Study:

  • To investigate the onset, progression, and L-Dopa responsiveness of micrographia in Parkinson's disease.
  • To utilize artificial intelligence (AI)-based pen-and-paper handwriting analysis as a non-invasive tool.

Main Methods:

  • Fifty-seven PD patients and 25 controls completed handwriting tasks.
  • Handwriting samples were analyzed using both clinical (perceptual) and AI-based (automatic) methods.
  • AI models, including convolutional neural networks (CNNs), were evaluated for classification accuracy.

Main Results:

  • AI analysis confirmed micrographia in PD patients, manifesting early and worsening progressively.
  • AI models accurately distinguished PD patients from controls (91%) and early from advanced PD (77%).
  • Micrographia showed poor response to L-Dopa, and AI could not differentiate OFF/ON states.

Conclusions:

  • AI-based handwriting analysis is a valuable, non-invasive tool for detecting and quantifying micrographia in PD.
  • This AI approach supports telemedicine applications for Parkinson's disease management.
  • AI analysis provides objective insights into PD progression and treatment response.